Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decylamine SCHEMBL25432939 | 1.00 | DNM1 (0.54) | DNM1TSHRTHRB | |
| SCHEMBL3922022 | 1.00 | DNM1 (0.54) | DNM1TSHRTHRB | |
| Dodecylamine SCHEMBL21176121 | 1.00 | DNM1 (0.54) | DNM1TSHRTHRB | |
| Butylamine SCHEMBL392393 | 0.91 | DNM1 (0.40) | DNM1 | |
| Butylamine SCHEMBL7165869 | 0.91 | DNM1 (0.40) | DNM1 | |
| Butylamine SCHEMBL14836807 | 0.91 | DNM1 (0.40) | DNM1 | |
| Octane SCHEMBL29076189 | 0.89 | TSHR (0.42) | DNM1TSHRTHRB | |
| Octane SCHEMBL23754699 | 0.87 | TSHR (0.40) | DNM1TSHRTHRB | |
| Propylamine SCHEMBL5081968 | 0.84 | — | — | |
| SCHEMBL4581617 | 0.83 | TSHR (0.36) | TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115109099-A | Transition metal compound, catalyst composition comprising the same, and ligand thereof | LG化学株式会社 | 2022-09-27 | — | — | CN | disclosed |
| CN-110621681-B | Novel transition metal compound and method for producing same | LG化学株式会社 | 2022-07-29 | — | — | CN | disclosed |
| US-11225495-B2 | Transition metal compound and method for preparing the same | LG CHEM, LTD. | 2022-01-18 | — | — | US | disclosed |
| EP-3611177-B1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2021-05-19 | — | — | EP | disclosed |
| US-20210032274-A1 | Novel Transition Metal Compound and Method for Preparing the Same | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
| EP-3219719-B1 | TRANSITION METAL COMPOUND AND CATALYST COMPOSITION CONTAINING SAME | LG CHEMICAL LTD (KR) | 2020-12-23 | — | — | EP | disclosed |
| EP-3222622-B1 | TRANSITION METAL COMPOUND AND CATALYST COMPOSITION CONTAINING SAME | LG CHEMICAL LTD (KR) | 2020-12-23 | — | — | EP | disclosed |
| US-10590215-B2 | Transition metal compound and catalyst composition including the same | LG CHEM, LTD. (KR) | 2020-03-17 | — | — | US | disclosed |
| EP-3611177-A1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG Chem, Ltd. (KR) | 2020-02-19 | — | — | EP | disclosed |
| US-10550204-B2 | Transition metal compound and catalyst composition including the same | LG CHEM, LTD. (KR) | 2020-02-04 | — | — | US | disclosed |
| EP-2457894-B1 | NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUND | LG CHEMICAL LTD (KR) | 2014-01-22 | — | — | EP | disclosed |
| US-20120259077-A1 | MIXED METALLOCENE CATALYST COMPOSITION AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | LG CHEM, LTD. (KR) | 2012-10-11 | — | — | US | disclosed |
| US-20120196994-A1 | NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUNDS | LG CHEM, LTD. (KR) | 2012-08-02 | — | — | US | disclosed |
| EP-2457894-A2 | NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUND | LG Chem, Ltd. (KR) | 2012-05-30 | — | — | EP | disclosed |
| EP-2450384-A2 | METHOD FOR PRODUCING AN ELASTOMER USING A TRANSITION METAL CATALYST | LG Chem, Ltd. (KR) | 2012-05-09 | — | — | EP | disclosed |
| US-20120108772-A1 | METHOD FOR PRODUCING AN ELASTOMER USING A TRANSITION METAL CATALYST | LG CHEM, LTD. (KR) | 2012-05-03 | — | — | US | disclosed |
| US-7517940-B2 | Catalyst composition including transition metal complexes and olefin polymerization using the same | LG CHEM, LTD. (KR) | 2009-04-14 | — | — | US | disclosed |
| WO-2007089112-A1 | CATALYST COMPOSITION INCLUDING TRANSITION METAL COMPLEXES AND OLEFIN POLYMERIZATION USING THE SAME | LG CHEM, LTD. (KR) | 2007-08-09 | — | — | WO | disclosed |
| US-20070179046-A1 | CATALYST COMPOSITION INCLUDING TRANSITION METAL COMPLEXES AND OLEFIN POLYMERIZATION USING THE SAME | LG CHEM, LTD. (KR) | 2007-08-02 | — | — | US | disclosed |
| US-6319979-B1 | HAVING A DENSITY OF 0.850-0.895 G/CM.3 ; TACKIFYING RESIN; AND UP TO 40 WEIGHT PERCENT OF AT LEAST ONE WAX, VISCOSITY OF LESS THAN ABOUT 5000 CPS (50 GRAMS/(CM.SECOND)) AT 150 DEGREES C. | THE DOW CHEMICAL COMPANY | 2001-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550204-B2 | Transition metal compound and catalyst composition including the same | ZCCHC8, ZNF436-AS1, ORC3 | DNM1 77/4885TSHR 4836/4885THRB 4881/4885 |
| US-20120196994-A1 | NOVEL POST METALLOCENE-TYPE TRANSITION METAL COMPOUNDS | ZC3HAV1L, ZKSCAN2, ZC3H18 | DNM1 423/4885TSHR 4757/4885THRB 4847/4885 |
| US-11225495-B2 | Transition metal compound and method for preparing the same | ODC1, TET1, MCM6 | DNM1 348/4885TSHR 4846/4885THRB 4878/4885 |
| US-20210032274-A1 | Novel Transition Metal Compound and Method for Preparing the Same | ODC1, MCM6, TET1 | DNM1 866/4885TSHR 4825/4885THRB 4867/4885 |
| US-10590215-B2 | Transition metal compound and catalyst composition including the same | SOD1, ZNF787, ALOX12 | DNM1 94/4885TSHR 4822/4885THRB 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.